2019 Dec
CANCER MEDICINE 공동저자
Feasible outcome of blinatumomab followed by allogeneic hematopoietic cell transplantation for adults with Philadelphia chromosome?negative acute lymphoblastic leukemia in first salvage

2019 Nov
INTERNATIONAL JOURNAL OF HEMATOLOGY 공동저자
A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation

2019 Nov
CANCER MEDICINE 공동저자
Clinical outcomes for ibrutinib in relapsed or refractory mantle cell lymphoma in real-world experience

2019 Nov
JOURNAL OF CLINICAL MEDICINE 공동저자
Simultaneous Monitoring of Mutation and Chimerism Using Next-Generation Sequencing in Myelodysplastic Syndrome

2019 Oct
EUROPEAN JOURNAL OF HAEMATOLOGY 제1저자
Reactivation and dynamics of cytomegalovirus and Epstein-Barr virus after rabbit antithymocyte globulin and cyclosporine for aplastic anemia

2019 Oct
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
WT1 measurable residual disease assay in patients with acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation: Optimal Time Points, Thersholds, and Candidates

2019 Oct
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease

2019 Oct
ANNALS OF SURGICAL ONCOLOGY 공동저자
Distinct Clinical Manifestations of Thyroid Cancer After Hematopoietic Stem Cell Transplantation

2019 Sep
BONE MARROW TRANSPLANTATION 제1저자
Excellent outcomes of hematopoietic stem cell transplantation with total nodal irradiation and antithymocyte globulin conditioning in severe aplastic anemia with advanced age and/or severe comorbidity

2019 Aug
SCIENTIFIC REPORTS 공동저자
Progressive hyperleukocytosis is a relevant predictive marker for differentiation syndrome, early death, and subsequent relapse in acute promyelocytic leukemia

2019 Jul
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 제1저자
A Phase I/II, Open-Label, Prospective, Multicenter Study to Evaluate the Efficacy and Safety of Lower Doses of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation: The KMM103 Study

2019 Jul
ANNALS OF HEMATOLOGY 공동저자
Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin's lymphoma

2019 Jun
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 공동저자
Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

2019 Mar
CANCER 공동저자
Minimal residual disease-based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia

2019 Feb
JOURNAL FOR IMMUNOTHERAPY OF CANCER 공동저자
Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation

2019 Feb
CANCER MEDICINE 공동저자
Improved survival outcomes and restoration of graft-vs-leukemia effect by deferasirox after allogeneic stem cell transplantation in acute myeloid leukemia

2019 Feb
HAEMATOLOGICA 공동저자
Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy

2019 Feb
BONE MARROW TRANSPLANTATION 공동저자
Autologous hematopoietic cell transplantation using dose-reduced intravenous busulfan, melphalan, and thiotepa for high-risk or relapsed lymphomas

2019 Feb
INTERNATIONAL JOURNAL OF STEM CELLS 공동저자
Predictive Role of Circulating Immune Cell Subtypes Early after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia

2019 Jan
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 제1저자
Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome

2019 Jan
JAPANESE JOURNAL OF CLINICAL ONCOLOGY 제1저자
Brief report: Clinical experiences after emergency use of daratumumab monotherapy for relapsed or refractory multiple myeloma in real practice

2018 Nov
ANNALS OF HEMATOLOGY 공동저자
Low frequency of CD3(+)CD4(+)CD161(+) T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatment

2018 Nov
AMERICAN JOURNAL OF HEMATOLOGY 공동저자
Optimal conditioning regimen for haplo-identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de-escalation study of TBI and ATG dose

2018 Oct
BONE MARROW TRANSPLANTATION 공동저자
Successful outcomes of second hematopoietic stem cell transplantation with total nodal irradiation and ATG conditioning for graft failure in adult patients with severe aplastic anemia

2018 Aug
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Impact of an Additional Chromosome on the Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Adults

2018 Apr
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 제1저자
Prognostic Prediction Model for Second Allogeneic Stem-Cell Transplantation in Patients With Relapsed Acute Myeloid Leukemia: Single-Center Report

2018 Jan
ONCOTARGET 공동저자
Comparison of the modified low-dose cytarabine and etoposide with decitabine therapy for elderly acute myeloid leukemia patients unfit for intensive chemotherapy